코로나바이러스감염증-19 대응을 위한 국가별 재정지원 방식 고찰: 의료기관에 대한 재정지원을 중심으로

Abstract

Korea initially adopted a policy of universal hospitalization for all confirmed cases of coronavirus disease 2019 (COVID-19) irrespective of symptoms, to prevent the spread of coronavirus in the absence of vaccines and treatments. However, this approach led to a shortage of beds to accommodate patients with COVID-19. To address this shortage, the government compensated those medical institutions that provided beds. This study reviewed the compensation methods and levels in Korea and foreign countries during COVID-19 pandemic to create a sustainable financial support system for future infectious disease situations. The study results are as follows: (Korea) The mortality rate of patients with COVID-19 is about 0.1%, and total expenditure due to COVID-19 is about 22.7 trillion won. (Japan) The mortality rate of patients with COVID-19 is about 0.2%, and total expenditure due to COVID-19 is about 106 trillion won. (Germany) The mortality rate of patients with COVID-19 is about 0.4%, and total expenditure due to COVID-19 is about 72 trillion won. (Taiwan) The mortality rate of patients with COVID-19 is about 0.4%, and total expenditure due to COVID-19 is about 7.8 trillion won. Many experts worldwide predict the occurrence of a large-scale infectious disease like COVID-19 in near future. This study is expected to serve as evidence for creating a sustainable financial support system in the event of a future infectious disease situation.